Endodontic variables in patients with SARS-CoV-2 infection (COVID-19) in relation to the severity of the disease

Autor: M. Poyato-Borrego, M. León-López, J. Martín-González, JM. Cisneros-Herreros, D. Cabanillas-Balsera, JJ. Segura-Egea

Publikováno v: Medicina Oral Patología Oral y Cirugia Bucal.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::68b84d73a7c179da0597409d841443a1
https://doi.org/10.4317/medoral.25773

DI-072 Relationship between the use of carbapenems and the incidence of extended spectrum beta-lactamase producing microorganisms in a tertiary hospital

Autor: María Antonia Pérez-Moreno, R Alma-Marin, JA Lepe-Jiménez, JM Cisneros-Herreros, MV Gil-Navarro, A Garcia-Avello

Publikováno v: Drug information and pharmacotherapy.

Background Extended spectrum beta-lactamases (ESBL) are enzymes produced by gram negative bacilli pathogens (mainly Escherichia coli and Klebsiella pneumoniae ) than confer resistance against penicillins, cephalosporins and aztreonam. Persistent expo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::195b4d833b97934b78bc173dc70ca8dc
https://doi.org/10.1136/ejhpharm-2017-000640.319

CMV Viral Replication Determined by Quantitative PCR and Pp-65 Antigenaemia after Allogeneic Hemopoietic Stem Cell Transplantation (ALO-HSCT)

Autor: Ildefonso Espigado, Pilar Pérez-Romero, Fáti ma de la Cruz Vicente, R. Parody Ruiz-Berdejo, A. Urbano-Ispizua, Jm. Cisneros-Herreros, Manuela Aguilar-Guisado

Publikováno v: Blood. 112:4380-4380

INTRODUCTION: More than 50 % of alo-HSCT recipients develop CMV infection. The best technique for early detection of viral replication has not already been defined. Antigenaemia is the most used technique but it presents limitations. Quantitative RT-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e6d4f8560b19a25359b251daf864abbd
https://doi.org/10.1182/blood.v112.11.4380.4380

[Infectious complications of heart transplantation. A prospective study for the first 6 years of a transplantation program]

Autor: Máximo Bernabeu-Wittel, Cañas García-Otero E, Herrero Romero M, Ordóñez Fernández A, Martínez Martínez A, Pérez Bernal J, Jm, Cisneros Herreros

Publikováno v: Europe PubMed Central

To study the infectious complications, mortality, and associated factors in heart transplant recipients.Prospective study of the first 69 heart transplantations performed from January 1991 until December 1996 in a university hospital. Description of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::9a32e9810731d079e5dd9d82e826f64a
http://europepmc.org/abstract/med/10522428

Survival of infection with TEM β-lactamase-producing Escherichia coli with Pan-β-lactam resistance.

Autor: Rodríguez-Villodres Á; Clinical Unit of Infectious Diseases, Microbiology and Parasitology, University Hospital Virgen del Rocío, Seville, Spain; Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain. Electronic address: anrovi1797@gmail.com., Ortiz de la Rosa JM; Clinical Unit of Infectious Diseases, Microbiology and Parasitology, University Hospital Virgen del Rocío, Seville, Spain; Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain., Gálvez-Benítez L; Clinical Unit of Infectious Diseases, Microbiology and Parasitology, University Hospital Virgen del Rocío, Seville, Spain; Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain., Gascón ML; Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain; Intensive Care Clinical Unit, Hospital Universitario Virgen de Rocío, Seville, Spain., Peñalva G; Clinical Unit of Infectious Diseases, Microbiology and Parasitology, University Hospital Virgen del Rocío, Seville, Spain; Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain., Dorado Pardo FJ; Clinical Unit of Infectious Diseases, Microbiology and Parasitology, University Hospital Virgen del Rocío, Seville, Spain; Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain., Casimiro-Soriguer CS; Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain; Andalusian Platform for Computational Medicine, Andalusian Public Foundation Progress and Health-FPS, Seville, Spain., Rodríguez Rodríguez M; Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain., Amaya Villar R; Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain; Intensive Care Clinical Unit, Hospital Universitario Virgen de Rocío, Seville, Spain., Cisneros JM; Clinical Unit of Infectious Diseases, Microbiology and Parasitology, University Hospital Virgen del Rocío, Seville, Spain; Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain; Faculty of Medicine, University of Seville, Seville, Spain., Lepe JA; Clinical Unit of Infectious Diseases, Microbiology and Parasitology, University Hospital Virgen del Rocío, Seville, Spain; Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain; Department of Microbiology, University of Seville, Seville, Spain.

Publikováno v: The Journal of infection [J Infect] 2024 Nov; Vol. 89 (5), pp. 106268. Date of Electronic Publication: 2024 Sep 13.